ThePharmyard Click here to see all DOVE Medical Press titles in ThePharmYard
Pay-as-you-go medical and pharmaceutical industry information About Us | Contact Us | Terms
The Publishers

Managing patient adherence and quality of life in epilepsy

Published in Neuropsychiatric Disease and Treatment, Drs Eatock and Baker review potential strategies in managing treatment adherence within epilepsy and their findings can equally be applied to other chronic conditions.

Product Details - See below for further product information
Note the document you buy is licensed for your own use only.

File type and size: PDF 0.162 MB
Publication size: 16 pages
Publication date: January 2007
Published by: Dove Medical Press
ThePharmYard product code: dove249

Our Price: £20.00
You are buying an e-document. This is a digital product and therefore UK VAT @ 17.50 % will be added at Checkout if your billing address is in the EU.

Related Products:

People who purchased this also purchased...

Further Product Information

AUTHORS:

Joanne Eatock and Gus A Baker of the Division of Neurological Science, University of Liverpool, UK

ABSTRACT

Patient adherence to medication continues to be a cause of concern within the medical profession. This review examines the various methods of quantifying the level of patient adherence, progress in predicting causes of non-adherence, and the implications for its management. Contributions from the medical, health belief, and psychosocial models are discussed in order to highlight how the concept of adherence has changed over time. The impact of epilepsy, seizures, and taking antiepileptic drugs (AEDs) on both adherence and quality of life are also explored. The volume and quality of previous research conducted has enabled a number of predictive factors to be identified, from which various strategies have been developed. While this review concentrates on potential strategies in managing treatment adherence within epilepsy, findings can equally be applied to other chronic conditions.



ABOUT THE JOURNAL

Neuropsychiatric Disease and Treatment is the official journal of the International Neuropsychiatric Association (INA)

ISSN 1176-6328

An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.

Affiliates | About Us | Contact Us | Terms

ThePharmYard is an initiative for the international medical and pharmaceutical industries from NetworkPharma Ltd. Copyright 2010

Other services managed by NetworkPharma: [www.EuropeanCMEforum.eu] [www.KeywordPharma.com] [www.MedCommsForum.com] [www.MedCommsNetworking.co.uk] [www.NetworkPharma.tv] [www.ThePublicationPlan.com]

We accept the following credit and debit cards: amex visa visa_delta visa_electron mastercard switch jcb solo